Prognostic subtypes are identified using machine learning techniques based on extracellular matrix characteristics, enhancing understanding of medulloblastoma.
The analysis reveals three distinct subtypes associated with varying outcomes in patients with SHH-activated medulloblastoma.
Observational analysis highlights the potential of using extracellular matrix markers for prognosis in medulloblastoma cases.
These findings may enable tailored treatment approaches but require external validation in diverse populations.